Crux vs EvoNexus: Revenue, Funding & Team Size Compared
Crux generates $11.7M in revenue; EvoNexus generates $11.6M. Crux and EvoNexus are close to the same size by revenue. The table below compares Crux and EvoNexus on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $11.7M | $11.6M |
| Valuation | Not disclosed | $116M |
| Team size | 74 | 63 |
| Founded | 2023 | 1998 |
| HQ | New York, United States | San Diego, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Crux at a glance
Crux generates $11.7M in revenue with 74 employees, headquartered in New York, United States.
- Revenue
- $11.7M
- Team size
- 74
- Founded
- 2023
Crux is the capital markets platform changing the way clean energy and manufacturing projects are financed in the US, and it also serves as an external data automation platform focused on the integration, transformation, and observability…
EvoNexus at a glance
EvoNexus generates $11.6M in revenue with 63 employees, headquartered in San Diego, United States.
- Revenue
- $11.6M
- Valuation
- $116M
- Team size
- 63
- Founded
- 1998
EvoNexus is a technology startup incubator with locations in San Diego, Orange County, and Silicon Valley. We enable motivated entrepreneurs to turn their transformative ideas into fundable, commercially-viable companies. We specialize in…
Other Crux alternatives
Crux competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Crux vs EvoNexus: frequently asked questions
Is Crux or EvoNexus bigger?
Crux is the bigger company by revenue, at $11.7M against $11.6M for EvoNexus.
How much revenue does Crux make?
Crux generates $11.7M in annual revenue with a team of 74.
How much revenue does EvoNexus make?
EvoNexus generates $11.6M in annual revenue with a team of 63.